1.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NHLBI Protocol IDs: NHLBI-00-H-0156, NCI-171, NCT00006240, 171
|
|
2.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 18 and over Sponsor: NCI, Pharmaceutical / Industry Protocol IDs: UCSD-050126, ROCHE-VAL-108, NCT00387530
|
|
3.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: J-9616, JHOC-9616, NCI-T95-0017H, NCT00002909, T95-0017
|
|
4.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NABTT-9605, JHOC-NABTT-9605, NCI-T96-0086
|